Classification of individual lung cancer cell lines based on DNA methylation markers: Use of linear discriminant analysis and artificial neural networks

Journal of Molecular Diagnostics

Volumn 6, Issue 1, 2004, Pages 28-36

  Marchevsky, Alberto M ^a   Tsou, Jeffrey A ^b   Laird Offringa, Ite A ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 2; DNA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ONCOPROTEIN;

ACCURACY; ARTICLE; ARTIFICIAL NEURAL NETWORK; AUTOMATION; CANCER CELL CULTURE; CANCER CLASSIFICATION; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DISCRIMINANT ANALYSIS; DNA METHYLATION; EXPERIMENTAL MODEL; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

EID: 1142263111     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60488-6     Document Type: Article

References (48)

1. Sullivan Pepe M, Etzioni R, Feng Z, Potter JD, Thompson MD, Thornquist M, Winget M, Yasui Y: Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001, 93:1054-1061
2. Marchevsky AM, Gil J, Jeanty H: Computerized interactive morphometry in pathology: current instrumentation and methods. Hum Pathol 1987, 18:320-331
3. Marchevsky AM, Hauptman E, Gil J, Watson C: Computerized interactive morphometry as an aid in the diagnosis of pleural effusions. Acta Cytol 1987, 31:131-136
4. Bartels PH, Thompson D, Weber JE: Image Analysis: A Primer for Pathologists. New York, Raven Press, 1994, pp 2
5. An CS, Petrovic LM, Reyter I, Tolmachoff T, Ferrell LD, Thung SN, Geller SA, Marchevsky AM: The application of image analysis and neural network technology to the study of large-cell liver-cell dysplasia and hepatocellular carcinoma. Hepatology 1997, 26:1224-1231
6. Walts AE, Morimoto R, Marchevsky AM: Computerized interactive morphometry and the diagnosis of lymphoid-rich effusions. Am J Clin Pathol 1993, 99:570-575
7. Walts AE, Marchevsky AM: Computerized interactive morphometry: an expert system for the diagnosis of lymphoid-rich effusions. Am J Clin Pathol 1989, 92:765-772
8. Marchevsky AM, Klapper E, Gil J: Computerized classification of nuclear profiles in non-Hodgkin's lymphomas. Am J Clin Pathol 1987, 87:561-568
9. Marchevsky AM, Gil J: Applications of computerized interactive morphometry in pathology: II. a model for computer-generated diagnosis. Lab Invest 1986, 54:708-716
10. Marchevsky A, Gil J, Silage D: Computerized interactive morphometry as a potentially useful tool for the classification of non-Hodgkin's lymphomas. Cancer 1986, 57:1544-1549
11. Cenci M, Nagar C, Vecchione A: PAPNET-assisted primary screening of conventional cervical smears. Anticancer Res 2000, 20:3887-3889
12. Mango LJ, Radensky PW: Re-screening of cervical Papanicolaou smears using PAPNET. JAMA 1998, 279:1786-1787
13. Troni GM, Cipparrone I, Cariaggi MP, Ciatto S, Miccinesi G, Zappa M, Confortini M: Detection of false-negative Pap smears using the PAPNET system. Tumori 2000, 86:455-457
14. Travis WD, Colby TV, Corrin B, Shimosato Y: Histological Typing of Lung and Pleural Tumours. Berlin, Springer Verlag 1999, pp 7-9
15. Marchevsky AM: Surgical Pathology of Lung Neoplasms. New York, Marcel Dekker, Inc, 1990, pp 77-211
16. Marchevsky AM, Gal AA, Shah S, Koss MN: Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol 2001, 116:466-472
17. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN: Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998, 22:934-944
18. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN: Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998, 29:272-279
19. Sozzi G: Molecular biology of lung cancer. Eur J Cancer 2001, 37(Suppl 7):S63-S73
20. Virmani AK, Tsou JA, Siegmund KD, Shen LY, Long TI, Laird PW, Gazdar AF, Laird-Offringa IA: Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Cancer Epidemiol Biomarkers Prev 2002, 11:291-297
21. Holliday R: The significance of DNA methylation in cellular aging. Basic Life Sci 1985, 35:269-283
22. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA: DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene, 2002, 21:5450-5461
23. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21
24. Costello JC, Plass C: Methylation matters. J Med Genet 2001, 38: 285-303
25. Robertson KD: DNA methylation, methyltransferases, and cancer. Oncogene 2001, 20:3139-3156
26. Wade PA: Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene 2001, 20:3166-3173
27. Baylin SB, Esteller M, Rountree MR, Bachman KE:, Schuebel K, Herman JG: Aberrant patterns of DNA methylation, chromatin formation, and gene expression in cancer. Hum Mol Genet 2001, 10:687-692
28. Jones PA, Laird PW: Cancer epigenetics coming of age. Nat Genet 1999, 21:163-167
29. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999, 59:67-70
30. Costello JC, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa. R, Huang JJS, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C: Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat Genet 2000, 25:132-138
31. Esteller M, Corn PG, Baylin SB, Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 2001, 61:3225-3229
32. Marchevsky AM, Shah S, Patel S: Reasoning with uncertainty in pathology: artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer patients. Mod Pathol 1999, 12:505-513
33. Singson RP, Alsabeh R, Geller SA, Marchevsky A: Estimation of tumor stage and lymph node status in patients with colorectall adenocarcinoma using probabilistic neural networks and logistic regression. Mod Pathol 1999, 12:479-484
34. Marchevsky AM, Patel S, Wiley KJ, Stephenson MA, Gondo, M, Brown RW, Yi ES, Benedict WF, Anton RC, Cagle PT: Artificial neural networks and logistic regression as tools for prediction of survival in patients with stages I and II non-small cell lung cancer. Mod Pathol 1998, 11:618-625
35. Bellotti M, Elsner B, Paez DL, Esteva H, Marchevsky AM: Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung. Mod Pathol 1997, 10:1221-1227
36. Marchevsky AM, Truong H, Tolmachoff T: A rule-based expert system for the automatic classification of DNA "ploidy" histograms measured by the CAS 200 image analysis system. Cytometry 1997, 30:39-46
37. Marchevsky AM, Coons G: Expert systems as an aid for the pathologist's role of clinical consultant: CANCER-STAGE. Mod Pathol 1993, 6:265-269
38. Marchevsky AM: Expert systems for efficient handling of medical information: I. lung cancer. Anal Quant Cytol Histol 1991, 13:89-92
39. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001, 7:673-679
40. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD, Mulshine JL: NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl 1996, 24:32-91
41. Olek A, Oswald J, Walter J: A modified and improved method for bisulphite-based cytosine methylation analysis. Nuclei Acids Res 1996, 24:5064-5066
42. Eads CA, Denenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Denenberg PV, Laird PW: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32
43. Trinh BN, Long TI, Laird PW: DNA methylation analysis by MethyLight technology. Methods 2001, 25:456-462
44. Rolston DW: Principles of Artificial Intelligence and Expert System Development. New York, McGraw-Hill Book Company, 1988
45. Afifi AA, Clark V: Computer-aided multivariate analysis. New York, Chapman & Hall/CRC, 1999, pp 243-280
46. Fleiss JL, Cuzick J: The reliability of dichotomous judgements: unequal numbers of judgements per subject: applied psychological measurement. Applied Psychol Meas 2003, 27:537-542
47. Marchevsky AM, Nelson V, Martin SE, Greaves TS, Raza AS, Zeineh J, Cobb CJ: Telecytology of fine needle aspiration biopsies of the pancreas: a study of well-differentiated adenocarcinoma and chronic pancreatitis with atypical epithelial repair changes. Diagn Cytopathol 2003, 28:147-152
48. Paz MF, Fraga MF, Avila S, Guo M, Pollan IM, Herman JG, Esteller M: A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003, 63:1114-1121